Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Serum level of co-expressed hub miRNAs as diagnostic and prognostic biomarkers for pancreatic ductal adenocarcinoma.

Su Q, Zhu EC, Qu YL, Wang DY, Qu WW, Zhang CG, Wu T, Gao ZH.

J Cancer. 2018 Oct 11;9(21):3991-3999. doi: 10.7150/jca.27697. eCollection 2018.

2.

Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer.

Wang N, Guo H, Dong Z, Chen Q, Zhang X, Shen W, Bao Y, Wang X.

Cancer Manag Res. 2018 Sep 12;10:3463-3471. doi: 10.2147/CMAR.S170481. eCollection 2018.

3.

Using microRNAs as Novel Predictors of Urologic Cancer Survival: An Integrated Analysis.

Chen Z, Zhan Y, Chi J, Guo S, Zhong X, He A, Zheng J, Gong Y, Li X, Zhou L.

EBioMedicine. 2018 Aug;34:94-107. doi: 10.1016/j.ebiom.2018.07.014. Epub 2018 Jul 21.

4.

A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.

Inamoto T, Uehara H, Akao Y, Ibuki N, Komura K, Takahara K, Takai T, Uchimoto T, Saito K, Tanda N, Yoshikawa Y, Minami K, Hirano H, Nomi H, Kato R, Hayashi T, Azuma H.

Dis Markers. 2018 Jun 20;2018:5468672. doi: 10.1155/2018/5468672. eCollection 2018.

6.

Identification of microRNA differentially expressed in three subtypes of non-small cell lung cancer and in silico functional analysis.

Hu Y, Wang L, Gu J, Qu K, Wang Y.

Oncotarget. 2017 Aug 12;8(43):74554-74566. doi: 10.18632/oncotarget.20218. eCollection 2017 Sep 26.

7.

Identification of microRNAs as potential biomarkers for lung adenocarcinoma using integrating genomics analysis.

Peng Z, Pan L, Niu Z, Li W, Dang X, Wan L, Zhang R, Yang S.

Oncotarget. 2017 Jul 18;8(38):64143-64156. doi: 10.18632/oncotarget.19358. eCollection 2017 Sep 8.

8.

Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR.

Castellano L, Dabrowska A, Pellegrino L, Ottaviani S, Cathcart P, Frampton AE, Krell J, Stebbing J.

Nucleic Acids Res. 2017 May 5;45(8):4401-4412. doi: 10.1093/nar/gkx022.

9.

YM500v3: a database for small RNA sequencing in human cancer research.

Chung IF, Chang SJ, Chen CY, Liu SH, Li CY, Chan CH, Shih CC, Cheng WC.

Nucleic Acids Res. 2017 Jan 4;45(D1):D925-D931. doi: 10.1093/nar/gkw1084. Epub 2016 Nov 29.

10.

Rs3842530 Polymorphism in MicroRNA-205 Host Gene in Lung and Breast Cancer Patients.

Zou F, Li J, Jie X, Peng X, Fan R, Wang M, Wang J, Liu Z, Li H, Deng H, Yang X, Luo D.

Med Sci Monit. 2016 Nov 25 [revised 2016 Jan 1];22:4555-5464.

11.

Extracellular miRNA-21 as a novel biomarker in glioma: Evidence from meta-analysis, clinical validation and experimental investigations.

Qu K, Lin T, Pang Q, Liu T, Wang Z, Tai M, Meng F, Zhang J, Wan Y, Mao P, Dong X, Liu C, Niu W, Dong S.

Oncotarget. 2016 Jun 7;7(23):33994-4010. doi: 10.18632/oncotarget.9188. Review.

12.

miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.

Bahena-Ocampo I, Espinosa M, Ceballos-Cancino G, Lizarraga F, Campos-Arroyo D, Schwarz A, Maldonado V, Melendez-Zajgla J, Garcia‚ÄźLopez P.

EMBO Rep. 2016 May;17(5):648-58. doi: 10.15252/embr.201540678. Epub 2016 Apr 9. Erratum in: EMBO Rep. 2016 Jul;17 (7):1081.

13.

Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.

Dong P, Ihira K, Xiong Y, Watari H, Hanley SJ, Yamada T, Hosaka M, Kudo M, Yue J, Sakuragi N.

Oncotarget. 2016 Apr 12;7(15):20260-70. doi: 10.18632/oncotarget.7754.

14.

Function and clinical potential of microRNAs in hepatocellular carcinoma.

Wang L, Yue Y, Wang X, Jin H.

Oncol Lett. 2015 Dec;10(6):3345-3353. Epub 2015 Sep 29.

15.

High MicroRNA-370 Expression Correlates with Tumor Progression and Poor Prognosis in Breast Cancer.

Sim J, Ahn H, Abdul R, Kim H, Yi KJ, Chung YM, Chung MS, Paik SS, Song YS, Jang K.

J Breast Cancer. 2015 Dec;18(4):323-8. doi: 10.4048/jbc.2015.18.4.323. Epub 2015 Dec 23.

16.

MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist.

Sun X, Cui M, Zhang A, Tong L, Wang K, Li K, Wang X, Sun Z, Zhang H.

J Exp Clin Cancer Res. 2016 Jan 13;35:10. doi: 10.1186/s13046-016-0288-0.

Supplemental Content

Support Center